C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
167/104, 530/13,
C12N 15/38 (2006.01) A61K 39/245 (2006.01) A61K 39/255 (2006.01) C07K 14/03 (2006.01) C07K 14/055 (2006.01) C12N 9/02 (2006.01) C12N 9/12 (2006.01) C12N 15/00 (2006.01) C12N 15/63 (2006.01) C12N 15/86 (2006.01) C12N 15/869 (2006.01) A61K 38/00 (2006.01) A61K 39/00 (2006.01)
Patent
CA 1341308
A vaccine effective against Marek's disease virus (MDV) comprises (a) an MDV attenuated by virtue of being TK- or (b) a host expressing an MDV antigen, namely the respective MDV homologues of the HSV gB, gC, gD or gH glycoproteins (or antigenic parts thereof) or the respective MDV homologues of the HSV-1 immediate early genes IE-68 or IE-175. The host may be a herpes virus of turkeys (HVT), more particularly HVT in which the MDV antigen is inserted in the HVT homologue of the HSV gC gene, the ribonucleotide reductase (large subunit) gene or the thymidine kinase (TK) gene.
611210
Binns Matthew Mckinley
Ross Louis Joseph Norman
Scott Simon David
Fetherstonhaugh & Co.
Merial Societe Par Actions Simplifiee
Rhone Merieux
LandOfFree
Vaccines against avian herpes viruses does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccines against avian herpes viruses, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccines against avian herpes viruses will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1319184